|
Volumn 107, Issue 6, 2000, Pages 1171-1177
|
Effects of systemic β-blocker therapy on the efficacy and safety of topical brimonidine and timolol
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT;
ATENOLOL;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
BRIMONIDINE;
METOPROLOL;
NADOLOL;
PROPRANOLOL;
TIMOLOL;
ADULT;
AGED;
ANTIHYPERTENSIVE ACTIVITY;
ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DIASTOLIC BLOOD PRESSURE;
DOUBLE BLIND PROCEDURE;
DRUG EFFICACY;
DRUG SAFETY;
FEMALE;
FOREIGN BODY;
HEADACHE;
HEART RATE;
HUMAN;
HYPEREMIA;
INTRAOCULAR HYPERTENSION;
INTRAOCULAR PRESSURE;
MAJOR CLINICAL STUDY;
MALE;
MULTICENTER STUDY;
OPEN ANGLE GLAUCOMA;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
XEROSTOMIA;
ADMINISTRATION, ORAL;
ADMINISTRATION, TOPICAL;
ADRENERGIC ALPHA-AGONISTS;
ADRENERGIC BETA-ANTAGONISTS;
BLOOD PRESSURE;
DOUBLE-BLIND METHOD;
FEMALE;
GLAUCOMA, OPEN-ANGLE;
HEART RATE;
HUMANS;
INTRAOCULAR PRESSURE;
MALE;
MIDDLE AGED;
OCULAR HYPERTENSION;
OPHTHALMIC SOLUTIONS;
PROSPECTIVE STUDIES;
QUINOXALINES;
SAFETY;
TIMOLOL;
|
EID: 0033768959
PISSN: 01616420
EISSN: None
Source Type: Journal
DOI: 10.1016/S0161-6420(00)00081-6 Document Type: Article |
Times cited : (80)
|
References (11)
|